We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Jekyll and Hyde: Tumor Suppressor and Driver of Malignancy and Metastasis

News   Feb 28, 2018 | Original story from University of California San Diego

 
Jekyll and Hyde: Tumor Suppressor and Driver of Malignancy and Metastasis

Human colon cancer cells with cell nuclei stained red. Credit: National Cancer Institute

 
 
 

RELATED ARTICLES

Leukemia Stem Cells Rely on Amino Acids for Survival

News

Clinically relevant eradication of leukemia stem cells could be achieved with drugs that target their metabolic vulnerabilities.

READ MORE

Anti-Malaria Drugs Show Promise in Treating Cancer – Now We Know Why

News

Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly what the chloroquines were targeting when they attack a tumor. Now, researchers say they have identified that target - an enzyme called PPT1 - opening up a new pathway for potential cancer treatments.

READ MORE

Dramatic Increase in E-Cigarette Use Among Youth

News

Sharp rise in e-cigarette use results in uptick in overall tobacco product use; prompts new, forceful steps by FDA to firmly confront and reverse youth epidemic.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE